Pfizer's RSV vaccine to protect babies gets greenlight from FDA
The Food and Drug Administration has approved the first vaccine for expectant mothers to shield their babies from RSV.
pfizer
Tornado damage to Pfizer factory highlights vulnerabilities of drug supply
A tornado that ripped through a Pfizer plant in Rocky Mount, N.C., raised worries about shortages of medicines used in hospitals. The drugs include commonly used painkillers and anesthetics.
Tornado damages Pfizer plant in North Carolina as scorching heat and floods sock other parts of US
A tornado heavily damaged a major Pfizer pharmaceutical plant in North Carolina on Wednesday, while torrential rain flooded communities in Kentucky and an area from California to South Florida endu
Pfizer warns of a looming penicillin supply shortage
The shortage comes as there has been a steady increase in rates of syphilis since 2000. Inventory can start depleting as early as this month, Pfizer said.
FDA advisers support approval of RSV vaccine to protect infants
At least 58,000 childern younger than 5 years old are hospitalized each year with RSV infections. A Pfizer vaccine given to pregnant people could help protect their infants from severe RSV illness.
CDC recommends new booster shots to fight omicron
CDC Director Rochelle Walensky has signed off on updated versions of the Moderna and Pfizer-BioNTech vaccines that target the original virus and the omicron subvariants.
FDA authorizes first revamp of COVID vaccines to target omicron
The new shots from Moderna and Pfizer-BioNTech target both the original strain of the coronavirus and the omicron BA.4/BA.5 subvariants that most people are catching now.
Moderna sues Pfizer over COVID-19 vaccine patents
The vaccine maker alleges that its rivals Pfizer and BioNTech used some patented features of its mRNA technology to develop their COVID vaccines.
Pfizer asks FDA to greenlight new omicron booster shots, which could arrive this fall
Pfizer has submitted data on its bivalent COVID-19 booster shot that specifically targets the latest omicron subvariants. If authorized, the company says the shots could be ready as soon as September.
Advisers to the FDA back COVID vaccines for the youngest children
A committee of experts voted unanimously to recommend that the Food and Drug Administration authorize COVID-19 vaccines from Moderna and Pfizer-BioNTech for children as young as 6-months-old.